O-I Glass, Inc., through its subsidiaries, manufactures and sells glass containers to food and beverage manufacturers primarily in the Americas, Europe, and the Asia Pacific. The company produces glass containers for alcoholic beverages, including beer, flavored malt beverages, spirits, and wine. It is also involved in the production of glass packaging for various food items, soft drinks, tea, juices, and pharmaceuticals. In addition, the company offers glass containers in a range of sizes, shapes, and colors. It sells its products directly to customers under annual or multi-year supply agreements, as well as through distributors. The company was founded in 1903 and is headquartered in Perrysburg, Ohio.

O-I Glass, Inc.

Glass Health

Glass Health is thrilled to announce our $5M seed round led by Initialized Capital. 🎉

Our latest funding will further our mission to empower clinicians with generative AI for clinical decision support.

We’re proud to count prominent healthcare founders as mentors and investors in this seed round, including Tom Lee, founder of One Medical, Epocrates, and Galileo Health; Connor Landgraf, founder of Eko Health; and Heather Hasson & Trina Spear, the co-founders of FIGS.

https://lnkd.in/gfA9xW6w

#Y Combinator #Breyer Capital #Initialized Capital

Our Glass AI CDS platform has been upgraded with a new core feature...🥁🎁

Glass Consult is our NEW clinical reference chatbot✨

Consult uses physician-validated context to answer clinical reference questions with in-text references at glass.health🎊🦾

Check out Glass Consult in action above, featuring physician-validated context on Acute Appendicitis by Glass Health AI Clinical Fellows & AI Editors, Marianne Ruelle, MD; Deven Patel, MD; & Gurbani Kaur, MD

#AI #AICDS #healthcareinnovation #healthcaretechnology #aiinhealthcare 

Y Combinator Initialized Capital

Tomorrow is almost here...

#healthcareinnovation #ai #healthcare #healthcaretechnology #AICDS

Introducing History & Physical Mode! 

Clinicians, we heard your request for better handling of complex cases by Glass AI. Starting today, you can input a full H&P to draft AI-assisted differential diagnoses and clinical plans. 

Try H&P Mode now at http://glass.health

This update includes major upgrades to the Glass user interface and its ability to assist with differential diagnosis and clinical plan drafting. Clinical training of Glass AI is ongoing by the Glass Health team of academic clinical contributors.

Glass AI is an experimental product in development. Given ongoing development and LLM limitations, all AI results should be supervised at the level of a trainee, interpreted cautiously, and should never replace clinician knowledge or judgment.

#healthcareinnovation #ai #aiinhealthcare Y Combinator

Glass Health's mission to empower clinicians with AI-assisted diagnosis and clinical decision-making is featured in this recent piece by the World Economic Forum 🏥 

https://lnkd.in/ehQa48Mk

🎊 New Updates to Glass AI🎊

The Glass Health team has trained Glass AI to draft clinical plans for new topics!

Check out our new handling of...
- hypoxemia
- hemoptysis
- community-acquired PNA

We're also sharpening Glass AI's ability to develop a DDx for high-yield medicine topics, including:

- hypoxemia
- constipation
- TIA
- UTI.

Just try entering a one-liner at http://glass.health. Glass AI will suggest 5 potential diagnoses to consider.

#ai #healthcare #healthtech #medicine Y Combinator Dereck Paul, MD Graham Ramsey

🚨 NEW Version of Glass AI Available 🚨 

Glass AI 2.0 combines an LLM with a clinical knowledge database created by our clinician team.

With clinician training, we create better DDx and Clinical Plan outputs than base LLMs.

Try 2.0 now at http://glass.health/ai

Clinicians have trained Glass AI 2.0 for this first release on a select group of high-yield medical topics.

Training is ongoing and you can view the full list of medical topics included in this release within the product.

Glass AI is in development to assist clinicians with differential diagnosis, evidence-based Tx, and documentation.

We make advances with your feedback and thank the community who has used Glass AI 1.0 over the past few weeks.

Please remember, Glass AI is a reference tool and assistant, like a smart textbook. It does not replace clinician judgment and should always be supervised.

Notably, Glass AI was not created for the general public and does not generate general advice medical advice.

Today's release of Glass AI 2.0 is the collective effort of the incredible Glass AI Clinical Contributor team. Full credits within the Glass AI tab in the Glass platform.

cc: Dereck Paul, MD, Graham Ramsey, Y Combinator, Breyer Capital

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	6.97B -	6.78B 2.63%	6.16B 9.26%	6.70B 8.87%	6.87B 2.49%	6.88B 0.12%	6.69B 2.70%	6.09B 8.97%	6.36B 4.37%	6.86B 7.85%	7.11B 3.63%
cost of revenue	5.64B -	5.53B 1.86%	5.05B 8.77%	5.49B 8.80%	5.74B 4.48%	5.59B 2.48%	5.48B 1.98%	5.12B 6.64%	5.27B 2.87%	5.64B 7.16%	5.61B 0.60%
gross profit	1.33B -	1.25B 5.86%	1.11B 11.41%	1.21B 9.19%	1.13B 6.52%	1.28B 13.24%	1.21B 5.85%	972M 19.54%	1.09B 12.24%	1.21B 11.18%	1.50B 23.33%
selling and marketing expenses
general and administrative expenses	506M -	523M 3.36%	476M 8.99%	503M 5.67%	502M 0.20%	483M 3.78%
selling general and administrative expenses	506M -	523M 3.36%	476M 8.99%	503M 5.67%	502M 0.20%	483M 3.78%	439M 9.11%	403M 8.20%	433M 7.44%	496M 14.55%	540M 8.87%
research and development expenses	62M -	63M 1.61%	64M 1.59%	65M 1.56%	60M 7.69%	70M 16.67%	68M 2.86%	75M 10.29%	82M 9.33%	79M 3.66%	92M 16.46%
other expenses	-266M -	-214M 19.55%	-320M 49.53%	-76M 76.25%	-105M 38.16%	-269M 156.19%	-729M 171.00%	87M 111.93%	-118M 235.63%	299M 353.39%
cost and expenses	6.20B -	6.12B 1.40%	5.59B 8.68%	6.06B 8.45%	6.30B 3.96%	6.15B 2.40%	5.99B 2.55%	5.60B 6.56%	5.78B 3.29%	6.22B 7.56%	6.24B 0.37%
operating expenses	568M -	586M 3.17%	540M 7.85%	568M 5.19%	562M 1.06%	553M 1.60%	507M 8.32%	478M 5.72%	515M 7.74%	575M 11.65%	632M 9.91%
interest expense	239M -	230M 3.77%	251M 9.13%	272M 8.37%	268M 1.47%	261M 2.61%	311M 19.16%	265M 14.79%	216M 18.49%	239M 10.65%	-342M 243.10%
ebitda	971M -	965M 0.62%	734M 23.94%	1.12B 52.45%	1.04B 6.70%	1.04B 0.10%	559M 46.51%	1.10B 96.78%	1.01B 8.09%	1.51B 49.26%	864M 42.74%
operating income	763M -	598M 21.63%	570M 4.68%	605M 6.14%	530M 12.40%	709M 33.77%	50M 92.95%	618M 1,136%	548M 11.33%	1.04B 90.51%	864M 17.24%
depreciation and amortization	397M -	448M 12.85%	424M 5.36%	491M 15.80%	501M 2.04%	507M 1.20%	509M 0.39%	482M 5.30%	463M 3.94%	465M 0.43%
total other income expenses net	-199M -	-150M 24.62%	-260M 73.33%	-16M 93.85%	-28M 75%	-192M 585.71%	-311M 61.98%	-265M 14.79%	-216M 18.49%	-239M 10.65%	-797M 233.47%
income before tax	335M -	287M 14.33%	59M 79.44%	356M 503.39%	275M 22.75%	277M 0.73%	-261M 194.22%	353M 235.25%	332M 5.95%	805M 142.47%	67M 91.68%
income tax expense	120M -	92M 23.33%	106M 15.22%	119M 12.26%	70M 41.18%	108M 54.29%	118M 9.26%	89M 24.58%	167M 87.64%	178M 6.59%	-152M 185.39%
net income	184M -	144M 21.74%	-74M 151.39%	209M 382.43%	180M 13.88%	257M 42.78%	-379M 247.47%	249M 165.70%	149M 40.16%	584M 291.95%	219M 62.50%
weighted average shs out	164.43M -	164.72M 0.18%	161.17M 2.16%	161.86M 0.43%	162.74M 0.54%	160.13M 1.61%	155.25M 3.04%	156.81M 1.00%	157.15M 0.22%	155.31M 1.17%	154.65M 0.42%
weighted average shs out dil	165.83M -	166.05M 0.13%	161.17M 2.94%	162.82M 1.03%	164.65M 1.12%	162.09M 1.55%	155.25M 4.22%	158.78M 2.28%	160.31M 0.96%	158.99M 0.83%	154.65M 2.73%
eps	1.11 -	0.87 21.62%	-0.46 152.87%	1.29 380.43%	1.11 13.95%	1.60 44.14%	-2.44 252.50%	1.59 165.16%	0.95 40.25%	3.76 295.79%	1.42 62.23%
epsdiluted	1.11 -	0.87 21.62%	-0.46 152.87%	1.28 378.26%	1.10 14.06%	1.59 44.55%	-2.44 253.46%	1.57 164.34%	0.93 40.76%	3.67 294.62%	1.42 61.31%

COM:O-I

Glass Health

Last Close

12.85

22/11 21:00

Market Cap

1.64B

Beta: -

Volume Today

974.14K

Avg: -

Preview